Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Bilbel Capital 2024 Q4 Investor Letter | Buyside Digest

Back to Fund Profile (Bilbel Capital)

Primary Source Intelligence • Q4 2024 Letter Analysis

Bilbel Capital Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Bilbel Capital. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

Annualized+1.3816%

Digest Analysis

Quick Take

"Led by Turkish warehouse REIT Reysas benefiting from structural shortage and Swedish healthcare tech Intellego with secured $360M deal."

Executive Summary

Bilbel Capital delivered exceptional returns of 129.47% in 2024, bringing three-year annualized returns to 133.32%. The fund maintains a concentrated portfolio led by Reysas GYO (50.1%) and Intellego Technologies (34.8%). Reysas benefits from Turkey's structural warehouse shortage, requiring 20-40 million additional square meters over the next decade while generating steady rental income despite Turkey's challenging 50% interest rate environment. Intellego secured a $360M deal with Likang, adding significant value with EKN guarantees reducing payment risk. The manager sold Tianjin Development Holdings to increase Intellego exposure after the deal announcement. New positions include Seohee Construction, which operates a unique risk-reduced model in South Korea, and an undisclosed position trading below cash with secured future orders. The portfolio trades at attractive valuations with strong insider buying across holdings. Key risks include Turkey's economic instability and South Korea's demographic challenges, while catalysts include structural warehouse demand and secured healthcare technology contracts.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

88%

CautiousHigh

High Conviction (88%)

Extremely high conviction evidenced by 85% concentration in top two positions, specific position sizing decisions (selling Tianjin to buy more Intellego), and detailed fundamental analysis with precise valuation targets. Manager provides specific deal probabilities and financial projections, demonstrating strong conviction in thesis.

Growth Outlook

75%

BearishBullish

Bullish (75%)

The manager expresses strong optimism about specific structural opportunities, particularly Turkey's warehouse shortage creating 7-12% annual growth potential and Intellego's secured deals. Language emphasizes attractive valuations and growth prospects with minimal discussion of broader market concerns.

Risk Appetite

85%

DefensiveAggressive

Aggressive (85%)

Portfolio remains highly concentrated with top two positions representing 85% of assets. Manager actively increased exposure to Intellego after deal announcement and added new positions, demonstrating strong risk appetite and conviction in current holdings.

Capital Deployment

60%

De-riskingDeploying

Net Neutral (60%)

Manager actively rebalanced portfolio by selling Tianjin Development Holdings to increase Intellego exposure and added two new positions. While no cash levels are disclosed, the active portfolio management and new position additions suggest moderate deployment activity.

Forward Guidance

70%

CautiousExpansionary

Expansionary (70%)

Manager shows clear intent to maintain concentrated positioning and expects continued strong performance from structural trends. Discusses specific catalysts and growth drivers with confidence, though acknowledges some timing uncertainties in healthcare approvals.

Language Signal

80%

BearishBullish

Bullish (80%)

Language is predominantly positive with frequent use of opportunity-focused terms like 'attractive,' 'undervalued,' 'strong position,' and 'good deal.' Risk language is present but balanced with opportunity framing. Overall tone is constructive and optimistic.

Perceived Risk

45%

Low RiskElevated

Moderate Risk (45%)

Manager acknowledges specific risks including Turkey's economic challenges with 50% interest rates, South Korea's demographic decline, and healthcare approval timing. However, risks are discussed in context of mitigation strategies and don't dominate the narrative.

Opportunity Density

75%

ScarceAbundant

Abundant (75%)

Manager identifies multiple attractive opportunities including structural warehouse shortage in Turkey, secured healthcare deals, and companies trading below cash. Discussion of 'small companies that don't make sense' and finding undervalued positions suggests abundant opportunity set.

Time Horizon

80%

Short-TermLong-Term

Decade+ (80%)

Manager demonstrates long-term orientation with multi-year projections for Reysas (2026 targets), discussion of 10-year warehouse shortage resolution, and 5-year Intellego deal timeline. Focus on structural trends and competitive advantages indicates patient capital approach.